Skip to content

Balchem BCPC Specialty Products — Operating Income (Loss)

Other segment segments

Human Nutrition and Health
$40.02M+5.4%
Animal Nutrition and Health
$5.69M+8.7%

Similar metrics at other companies

Chart Industries logo
GTLSSpecialty Products — Operating Income (Loss)
$8.4M-82.6%
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Operating Income (Loss)
$50.06M+234%
APi Group logo
APGSpecialty Services — Operating Income (Loss)
$39M+34.5%
Illinois Tool Works logo
ITWSpecialty Products — Operating Income
$135M0.0%
Church & Dwight logo
CHDSpecialty Products Division — Operating Income
$10.9M-14.8%
Henry Schein logo
HSICGlobal Specialty Products — Operating Income
$58M+3.6%

Other financials

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation

See full
Market cap$5.33B+0.5%
Enterprise value$5.3B+0.1%
P/E33.7×-5.1×
P/S-0.5×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp
FCF margin14.9%

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's specialty products — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Balchem's specialty products — operating income (loss)?
Balchem (BCPC) reported specialty products — operating income (loss) of $11.94M in Q1 2026.
How has Balchem's specialty products — operating income (loss) changed year-over-year?
Balchem's specialty products — operating income (loss) increased by 24.5% year-over-year, from $9.59M to $11.94M.
What is the long-term trend for Balchem's specialty products — operating income (loss)?
Over 3 years (2022 to 2025), Balchem's specialty products — operating income (loss) has grown at a 9.4% compound annual growth rate (CAGR), from $32.79M to $42.9M.
What does specialty products — operating income (loss) mean?
Represents the profit or loss generated by the specialty products segment after deducting both cost of sales and operating expenses from net sales. This is a primary indicator of the segment's operational health and its contribution to the overall corporate bottom line.